Segurança CV da Dapagliflozina - estudo DECLARE - Carlos Eduardo Barra Couri - #Podcast 157

Feb 24, 2021

Autor: Carlos Eduardo Barra Couri

Ref: Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med. 2018 Nov 10.